Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Clinical Investigation to Evaluate the Safety and Efficacy of Glucosanol in Maintaining Body Weight Loss in Overweight and Obese Subjects

NCT01435278 is registered in ClinicalTrials.gov with InQpharm Group as lead sponsor.

NCT NCT01435278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01435278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Clinical Investigation to Evaluate the Safety and Efficacy of Glucosanol in Maintaining Body Weight Loss in Overweight and Obese Subjects
Lead sponsor
InQpharm Group
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2011
Completion date
July 31, 2012
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight